Company profile HEPA

Hepion Pharmaceuticals Inc
hepion pharmaceuticals, inc., a biopharmaceutical company, focuses on the development of pleiotropic drug therapy for the treatment of chronic liver diseases in the united states. it is involved in developing crv431, a cyclophilin inhibitor that has completed the phase i clinical trials for multiple biochemical pathways involved in the progression of liver diseases; and tenofov...ir exalidex, a lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the active antiviral agent tenofovir diphosphate for the treatment of hepatitis b. the company was formerly known as contravir pharmaceuticals, inc. and changed its name to hepion pharmaceuticals, inc. in july 2019. hepion pharmaceuticals, inc. was incorporated in 2013 and is headquartered in edison, new jersey. Show More
Quarter analysis & expected interest

There is not enough data for Hepion Pharmaceuticals near me to provide analysis

Correlation between past revenue and Hepion Pharmaceuticals near me search interest

There is not enough data for Hepion Pharmaceuticals near me to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Hepion Pharmaceuticals near me to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Hepion Pharmaceuticals login to provide analysis

Correlation between past revenue and Hepion Pharmaceuticals login search interest

There is not enough data for Hepion Pharmaceuticals login to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Hepion Pharmaceuticals login to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 05:48:25.

After 39 days of this quarter the interest is at 108.0. Based on that we can calculate that during remaining 52 days it will total up to 252.0.
Hepion Pharmaceuticals stock expected interest is significantly higher compared to previous quarter (+149.5%) and same quarter last year (+60.5%).

YearQ1Q2Q3Q4
201920
82
310.0% QoQ
217
164.6% QoQ
62
-71.4% QoQ
2020 141
605.0% YoY 127.4% QoQ
126
53.7% YoY -10.6% QoQ
19
-91.2% YoY -84.9% QoQ
133
114.5% YoY 600.0% QoQ
2021 189
34.0% YoY 42.1% QoQ
174
38.1% YoY -7.9% QoQ
177
831.6% YoY 1.7% QoQ
0
-100.0% YoY -100.0% QoQ
2022 84
-55.6% YoY inf% QoQ
88
-49.4% YoY 4.8% QoQ
82
-53.7% YoY -6.8% QoQ
17
inf% YoY -79.3% QoQ
2023 157
86.9% YoY 823.5% QoQ
45
-48.9% YoY -71.3% QoQ
126
53.7% YoY 180.0% QoQ
101
494.1% YoY -19.8% QoQ
2024 108
-31.2% YoY 6.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Hepion Pharmaceuticals stock search interestLast update: February 09 2024 05:48:24.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 05:48:26.

The average 5 years interest of Hepion Pharmaceuticals stock was 8.23 per week.
The last year interest of Hepion Pharmaceuticals stock compared to the last 5 years has changed by -2.07%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -4.95%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Hepion Pharmaceuticals CEO to provide analysis

Correlation between past revenue and Hepion Pharmaceuticals CEO search interest

There is not enough data for Hepion Pharmaceuticals CEO to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Hepion Pharmaceuticals CEO to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Hepion Pharmaceuticals drug development to provide analysis

Correlation between past revenue and Hepion Pharmaceuticals drug development search interest

There is not enough data for Hepion Pharmaceuticals drug development to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Hepion Pharmaceuticals drug development to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for chronic liver diseases treatment to provide analysis

Correlation between past revenue and chronic liver diseases treatment search interest

There is not enough data for chronic liver diseases treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for chronic liver diseases treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Rencofilstat clinical trials to provide analysis

Correlation between past revenue and Rencofilstat clinical trials search interest

There is not enough data for Rencofilstat clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Rencofilstat clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for non-alcoholic steatohepatitis treatment to provide analysis

Correlation between past revenue and non-alcoholic steatohepatitis treatment search interest

There is not enough data for non-alcoholic steatohepatitis treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for non-alcoholic steatohepatitis treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for liver fibrosis reduction to provide analysis

Correlation between past revenue and liver fibrosis reduction search interest

There is not enough data for liver fibrosis reduction to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for liver fibrosis reduction to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for liver inflammation reduction to provide analysis

Correlation between past revenue and liver inflammation reduction search interest

There is not enough data for liver inflammation reduction to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for liver inflammation reduction to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for HEPA
Earnings date: 2024-03-11 After close
Company name: Hepion Pharmaceuticals Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-03-03T12:35:00Z

GlobeNewswire
Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma

2025-07-22T16:54:26-04:00

SEC
25-NSE Form - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities - Hepion Pharmaceuticals, Inc. (0001583771) (Subject)

2025-06-25T12:30:00Z

GlobeNewswire
Hepion Pharmaceuticals Successfully Completes Application to the OTCQB

2025-06-12T16:28:14-04:00

SEC
8-K Form - Current report, item 5.07 - Hepion Pharmaceuticals, Inc. (0001583771) (Filer)

2025-06-09T16:30:26-04:00

SEC
8-K Form - Current report, item 5.02 - Hepion Pharmaceuticals, Inc. (0001583771) (Filer)

2025-05-30T16:30:34-04:00

SEC
8-K Form - Current report, item 1.01 - Hepion Pharmaceuticals, Inc. (0001583771) (Filer)

2025-05-19T17:30:01-04:00

SEC
10-Q Form - Quarterly report [Sections 13 or 15(d)] - Hepion Pharmaceuticals, Inc. (0001583771) (Filer)

2025-05-15T17:23:33-04:00

SEC
SCHEDULE 13G Form - Statement of Beneficial Ownership by Certain Investors - Hepion Pharmaceuticals, Inc. (0001583771) (Subject)

2025-05-15T16:30:28-04:00

SEC
NT 10-Q Form - Notification of inability to timely file Form 10-Q or 10-QSB - Hepion Pharmaceuticals, Inc. (0001583771) (Filer)

2025-05-12T17:00:12-04:00

SEC
8-K Form - Current report, items 3.01 and 9.01 - Hepion Pharmaceuticals, Inc. (0001583771) (Filer)

2025-05-12T20:30:00Z

GlobeNewswire
Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq

2025-05-07T12:30:00Z

GlobeNewswire
Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC

2025-05-06T08:59:37-04:00

SEC
8-K Form - Current report, items 1.01 and 3.02 - Hepion Pharmaceuticals, Inc. (0001583771) (Filer)

2025-04-29T06:09:30-04:00

SEC
ARS Form - Annual Report to Security Holders - Hepion Pharmaceuticals, Inc. (0001583771) (Filer)

2025-04-28T16:58:37-04:00

SEC
DEF 14A Form - Other definitive proxy statements - Hepion Pharmaceuticals, Inc. (0001583771) (Filer)